determined the natural history of 49 adult patients (12 primary IgA nephropathy, 13 thin GBM nephropathy, 20 normal renal tissue and 4 miscellaneous nephropathies) who presented with idiopathic non-proteinuric non-azotemic hematuria of at least six months duration, in the absence of hypertension and with a negative urological work-up. The median follow-up was 11 years with a range of 8 to 14 years. At the end of the follow-up, renal function had remained stable in all subsets except for those with miscellaneous disease. Hematuria was still present in all patients with thin GBM nephropathy, in all but two patients with IgA nephropathy who went into immunopathological remission, in three out of four miscellaneous nephropathies, and in seven out of 20 patients with normal renal tissue. Of the latter patients five had a history suggestive of urolithiasis at follow-up, which was in the absence of hypercalciuria and hyperuricosuria. Seven thin GBM patients, five IgA nephropathy patients and three miscellaneous nephropathies developed hypertension; the incidence of hypertension in each subset was significantly higher than in patients with normal renal tissue. This study shows that in young adults with idiopathic chronic non-proteinuric hematuria of four years duration, renal biopsy will give a definite diagnosis in 86% of the patients, and that those patients with so-called minor glomerular diseases are at high risk for hypertension. Those patients with normal renal tissue have a high incidence of urolithiasis and should have an urological follow-up.
Chronic non-azotemic and non-proteinuric hematuria, either recurrent macroscopic hematuria or persistent erythrocyturia, is usually considered, contrary to proteinuric hematuria, to be of urological origin. Patients presenting with these symptoms are referred to a urologist and are often subjected to several invasive diagnostic procedures. However, several nephrological diseases such as thin glomerular basement membrane nephropathy (thin GBM nephropathy), IgA nephropathy or interstitial nephritis are known to present with isolated hematuria [1] . The prognosis of these hematuric non-proteinuric patients is considered to be benign, but precise, long-term follow-up data are lacking, and defined cohorts of patients with appropriate controls are not available. In this paper we report on the long-term follow-up of 49 patients with chronic non-proteinuric hematuria, both of glomer- 
Methods

Patients
Patients were derived from a prospective epidemiological study conducted between 1978 and 1984 in three regional hospitals in the Netherlands, which served a total adherent population of 1.5 million. In this study incidence and natural history of idiopathic glomerulonephritis were determined by renal biopsy according to strict indications [1] . For a patient to be included in this analysis, chronic non-azotemic hematuria had to be present for more than six months, but, to ensure evaluation of patients early in the natural history of disease, renal biopsy had to be performed within two years after patient identification. Urological examination, including intravenous urography, ultrasonography, cystoscopy and, occasionally, renal arteriography had to be negative. Patients with known systemic disease, liver disorders, chronic hypertension, or from known families with hereditary renal disease were excluded from analysis.
Eighty-one adult patients, aged 16 to 65 years, were biopsied because of recurrent macroscopic hematuria or persistent erythrocyturia, defined as the consistent presence of more than five erythrocytes per high power field of centrifuged urine. Of these 81 patients, five patients (1 idiopathic IgA nephropathy, 2 mesangioproliferative glomerulonephritis and 2 with interstitial nephritis) presented with an increased serum creatinine concentration (> 140 j.tmol/liter) and hence were excluded. Two patients with thin GBM nephropathy and one patient with focal global glomerulosclerosis died during follow-up due to pancreatic carcinoma, lung carcinoma and a malignant lymphoma. Twenty-four patients were biopsied because of chronic hematuria in combination with significant proteinuria (> 500 mg/day), and therefore were excluded from this analysis. Thus 49 patients, of whom there were 12 patients with idiopathic IgA nephropathy, 13 patients with thin GBM nephropathy, 20 patients normal renal tissue and 4 with miscellaneous nephropathies [focal lymphocytic interstitial nephritis (2), old interstitial nephritis (1) , and focal global glomerulosclerosis (1)] were analyzed. In the cases of active interstitial nephritis the renal disorder was not caused by previous nephrotoxic medication and was not treated with steroids. None of the Mann-Whitney U test: P = 0.03 thin GBM vs normal Hg), increase in proteinuria (over 2x initial proteinuria) or a combination of these three. Renal biopsies were processed for light microscopy, immunofluorescence and ultrastructural analysis as described elsewhere [1] . Renal biopsies were classified according to the criteria as defined by the World Health Organization [21.
Glomerular basement membrane thickness was determined by the method of Steffes et al [3] . Using this method in adults a value of less than 260 nm is diagnostic for thin glomerular basal membranes [4] . The extent of focal global glomerulosclerosis in renal biopsies of all patients presenting with idiopathic hematuria was determined by counting the total number of glomeruli and the amount of scierosed glomeruli in at least five consecutive 2 fiLm sections, which were selected for the highest amount of glomeruli per section, stained with silver methenamin hematoxylin eosin.
Protein excretion was determined in a 24-hour urine collection using the biuret method, and adequate sampling was verified by measuring creatinine excretion in an automated analyzer based on the Jaffe reaction. Blood was drawn at the time of renal biopsy and at follow-up, allowed to clot for one hour at room temperature, and subsequently one hour on ice, serum was harvested and snap-frozen in liquid nitrogen. Serum samples were stored at -70°C until usage. At the time of renal biopsy the routine laboratory test included antinuclear and rheumatoid factor, antistreptolysin titer, classical hemolytic complement activity and liver function tests. In addition, in five patients with normal renal histology urinary calcium, phosphate, uric acid and creatinine excretion were determined. Hypercalciuria was said to exist when calcium excretion exceeded 4 mgIkgI24 hr, hyperuricosuria was present if uric acid exceeded 800 mg/24 hr in men or 750 mg/24 hr in women [5] . Statistical analysis was performed on the SPSS 4.0 statistical package for the Apple computer.
Results
At the entry of the study 18 of the 49 patients were biopsied because of recurrent macroscopic hematuria; in the remaining 31 patients persistent microscopic erythrocyturia was the indication for renal biopsy.
Of the 49 patients who were biopsied 67% (33 patients) had isolated hematuria; their 24-hour protein excretion did not exceed the physiological limit (< 180 mg/day). The remaining sixteen patients had proteinuria that corresponded to "trace" to "+" protein-excretion on the routine dipstick test, which in the 24-hour protein collection measured 180 to 500 mg/day. After a median follow-up of 11 years hematuria was still present in 33 patients (10 patients with idiopathic IgA nephropathy, in 7
patients with normal renal tissue and in 3 patients with miscellaneous nephropathies). All patients with thin GBM nephropathy showed persistent microscopic hematuria at follow-up. (Table 1) In IgA nephropathy resolution of hematuria occurred in two patients who had presented with persistent eiythrocyturia. Both underwent repeat renal biopsy. Histologically, there was regression of the mesangial proliferation. Immunofluorescence analysis showed that the deposition of immunoglobulin IgA1 and complement C3 had disappeared, and on ultrastructural examination mesangial electron-dense deposits were no longer demonstrable. In the group with miscellaneous nephropathies hematuria disappeared during follow-up in one patient with active focal interstitial nephritis.
Of the patients with normal renal tissue 13 (65%) spontaneously lost hematuria during follow-up. The median duration of persistent hematuria in normal renal tissue was 53 months after renal biopsy. Remission of hematuria was equally distributed over the patients with macroscopic and microscopic hematuria, although in patients with macroscopic hematuria more symptoms of urolithiasis (passage of a stone, visible stone fragments in the urine, symptoms of renal colic) were encountered (Table 3) . At the 11 year follow-up persistent hematuria was still present in seven patient with normal renal tissue. Five of these patients, of whom four were originally biopsied because of macroscopic hematuria, had symptoms suggestive of urolithiasis during followup. In two patients no cause was known for the hematuria (Table  3) . Twenty-four hour urinary calcium, phosphate and uric acid excretion were determined in five of the seven patients with normal renal tissue who had a history of urolithiasis or persistent hematuria, and no hypercalciuria or hyperuricosuria could be demonstrated.
Hypertension was present in all patient groups after a follow-up period of 11 years (median). In thin GBM nephropathy 7 out of 13 (54%) patients were hypertensive, in IgA nephropathy 5 out of 12 (42%), and the miscellaneous group 3 out of 4. In three patients with thin GBM nephropathy, one patient with IgA nephropathy and two patients with miscellaneous nephropathies development of hypertension coincided with an increase in proteinuria. An isolated increase in proteinuria was found in two patients with thin GBM disease, three patients with IgA nephropathy, and two patients with normal renal tissue (subsequently, diabetes mellitus of late onset was diagnosed in I of them). Two patients with active interstitial nephritis showed decreased creatinine clearances at follow-up ( Table 1 ). The incidence of hypertension was significantly higher both in the thin GBM nephropathy and IgA nephropathy patients, compared to patients with normal renal tissue on biopsy, as only one patient in the latter group developed hypertension in the context of a positive family history for hypertension ( Table 2) . At follow-up all patients had a normal serum creatinine concentration.
Because of the increased incidence of hypertension in thin GBM nephropathy renal biopsies were reassessed for histological changes. Apart from focal global glomerulosclerosis and some- significantly different from normal renal tissue nor from thin GBM nephropathy. The increased presence of focal global gbmerulosclerosis in thin GBM nephropathy was neither related to an increased total number of glomeruli (20 7 glomeruli/section in thin GBM nephropathy, 17 11 glomeruli/section in normal renal tissue; P = 0.09), nor caused by long standing hypertension, as only one patient showed signs of renal microvascular abnormalities indicative of hypertension (intima fibrosis of the interlobar arteries and hyalinosis of the afferent arterioles).
Focal global glomerulosclerosis was not secondary to interstitial nephritis, as none of the biopsies of thin GBM nephropathy showed substantial interstitial nephritis. Nor was the focal global glomerulosclerosis in thin GBM disease related to age.
Discussion
In this study we report on the follow-up of 49 patients who underwent renal biopsy because of chronic non-azotemic idiopathic hematuria with proteinuria less than 0.5 g/day ("trace" to "+" proteinuria on dipstick examination) and with a normal urological evaluation. From a previous study it was already known that the prevalence of IgA nephropathy and thin GBM nephropathy was identical in patients biopsied because of chronic hematuna [1] ; in this report the prevalence was 24% and 26%, respectively. This prevalence may differ between countries since it is influenced by the availability of transmission electron REF microscopy [6] , and organization of the local health care including urine analysis for insurance, sports and draft registration. It has been shown that clinical findings at presentation are not helpful in the differential diagnosis of patients with chronic hematuria, as patients with urological causes of bleeding could not be distinguished from those with glomerular hematuria [4] .
The role of renal biopsy in patients with non-proteinuric non-azotemic hematuria is a topic of debate, particularly after the introduction of urinary red cell morphology to differentiate between glomerular or non-glomerular hematuria. The initial claim [71 that the detection of dysmorphic erythrocytes by phase contrast microscopy could differentiate between glomerular and urological hematuria was refuted in a blind and controlled study [81. A recent paper showed that, of the dysmorphic erythrocytes identified by phase contrast microscopy, only the acanthocyte, which is characterized by a ring form with vesicle-like protrusions, is indicative of glomerular bleeding, with a specificity of 98% and a sensitivity of 52% provided that over 5% of the urinary erythrocytes have this configuration [9] . As this acanthocyte is not inducible by changes in osmolarity, pH or urinary protein concentration it is useful clinically. In fact, in vitro work has demonstrated that passage of erythrocytes through the nephron together with some degree of hemolysis is required for acanthocyte formation [10] . However, patients with IgA nephropathy and patients with minor glomerular abnormalities, like thin GBM nephropathy, tend to have a low percentage of acanthocytes in the urine [9] . Therefore renal biopsies remain necessary to differentiate chronic non-proteinuric glomerular hematuria from urological causes.
In this study we found that the cause of hematuria corresponded well with the persistence of hematuria during follow-up, since hematuria remained present in almost all patients with glomerular or interstitial diseases. Only two patients with IgA nephropathy were shown to be in clinical, histological and ultrastructural remission, a finding described previously only in children with IgA nephropathy [11] . Conversely, in more than 65% of the patients with normal renal tissue hematuria disappeared spontaneously during follow-up or was related to complaints suggestive of urolithiasis. We determined the excretion of calcium and uric acid in a 24-hour urine collection of five patients who had symptoms of urolithiasis with persistent erythrocyturia of unknown origin, but were unable to demonstrate any hypercalciuria or hyperuricosuria. In the evaluation of hypercalciuria no measurement of citrate was obtained. The possibility that stone formation was caused by a low urine citrate concentration has not been excluded. Similarly, no information about diet was obtained. It is well known that diet changes can reverse hypercalciuria and hyperuricosuria [5] .
Our study shows that non-proteinuric thin GBM nephropathy and IgA nephropathy carry an excellent prognosis in relation to development of renal insufficiency, but are definite risk factors for the development of hypertension. Similarly, increased proteinuria (with or without development of hypertension) develops in 36% of the patients with glomerular hematuria, suggesting a slowly progressive course of disease.
In contrast to patients with thin GBM nephropathy or IgA nephropathy, patients with interstitial nephritis show a significant decrease in creatinine clearance at the end of follow-up, illustrating a faster progression of disease. How the hypertension in thin GBM disease is brought about is not known; the increased presence of focal global glomerulosclerosis suggests a renal origin.
There is evidence that this disease is slowly progressive in some patients, since they may develop renal insufficiency [12] . The high incidence of hypertension in thin GBM and IgA nephropathy is noteworthy considering the fact that the patients with chronic non-proteinuric hematuria are often not eligible for renal biopsy and thus are subjected to prolonged follow-up on an outpatient basis [13] , which in our and other's [6] experience often leads to loss of the patient for medical evaluation or repeated urological examinations.
As the median duration of persistence of hematuria in normal renal tissue was four years it is advisable to perform renal biopsy on those patients in whom chronic non-proteinuric hematuria remains present for more than four years. In those patients nephrological causes of hematuria will be found in 86% of the biopsies. For adequate patient care it is important that these patients are diagnosed and checked regularly, as development of hypertension and/or proteinuria in the course of renal disease is usually an indication of slowly progressive renal disease and may contribute to development of renal failure. Therefore, we recommend that patients with idiopathic chronic and non-proteinuric hematuria that is present for over four years, with normal renal function, blood pressure and a normal urological evaluation, are subjected to renal biopsy to determine the cause of hematuria. When renal biopsy does not reveal any nephrological cause for hematuria patients should be under surveillance of a urologist, as these patients are liable to develop urolithiasis and occasionally malignancies [14] .
